% | $
Quotes you view appear here for quick access.

Muscle Pharm Corp. Message Board

  • fkk_kass fkk_kass Feb 3, 2014 8:37 AM Flag

    Q4 profitability is a function of share count

    For the nine months ending Sep 30, weighted shares outstanding were 6,626,125 and net loss was $13,729,627, or $2.07 per share.

    Management provided an estimated loss per share of $1.44 for 2013. Logically, then, Q4 should be break-even if the weighted shares outstanding for the twelve months ending Dec 31 come in around ($13,729,627 / $1.44), or 9,534,463. Below 9,534,463 represents a net profit for Q4, above 9,534,463 represents a net loss for Q4.

    Let's assume the weighted shares outstanding figure comes in at 8,000,000, which is absolutely higher than what the actual number will be. That equates to a loss for the year of (8,000,000 * $1.44) = $11,520,000. This suggests a NET profit (i.e., AFTER non-cash charges) for Q4 of $2M+.

    Which is pretty odd given that management just forecast a net profit of roughly $2.5M for 2014 after 36% revenue growth.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.090.00(0.00%)Sep 29 3:29 PMEDT